Pharmaceutical manufacturer Eli Lilly has announced a corporate transaction focused on a sector outside of its core obesity treatment portfolio. The move comes as financial analysts issue fresh warnings regarding market heavyweight Nvidia during the final trading hours of the week.

Additional information regarding the transaction terms and the specific warnings directed at Nvidia is anticipated to emerge as financial markets continue to process the latest updates.

Further details are expected as the story develops.